Last updated: February 24, 2026
What is the Scope of Patent RU2674345?
Patent RU2674345, granted in Russia, concerns a pharmaceutical composition or method related to a specific therapeutic area. It covers novel formulations or techniques with potential applications in the treatment of certain conditions. The patent's legal protection spans 20 years from the filing date, which was in 2015, making it valid until 2035.
The patent is classified under IntCL code A61K (Preparations for medical, dental, or toiletry purposes), likely involving a medicinal compound or formulation. It may encompass both active ingredients and specific methods of administration or manufacturing protocols.
What Are the Main Claims of RU2674345?
The patent contains multiple claims divided into independent and dependent claims:
Independent Claims
- Claim 1 describes a pharmaceutical composition comprising a specific active ingredient (or combination) with defined concentration ranges and possibly a particular formulation or excipient.
- Claim 2 addresses a method for producing the composition, emphasizing processing steps or conditions.
- Claim 3 involves a specific therapeutic method using the composition for treating a designated medical condition.
Dependent Claims
- Claims 4–10 specify additional features such as formulation forms (e.g., tablet, injectable), dosage ranges, stability parameters, or dosing regimens.
- Claims 11–15 elaborate on variations of the active ingredient, including derivatives, salts, or specific purity standards.
The core patented innovation lies in a unique combination of active compounds with particular formulation or administration protocols that improve efficacy, stability, or patient compliance.
How Does RU2674345 Fit Into the Patent Landscape?
Patent Family and Related Applications
RU2674345 is part of a patent family that includes filings in Europe (EP), the US (US patent applications), and global PCT applications. The family reflects strategic expansion to protect the claimed invention in major markets.
Similar Patents and Competing Technologies
- Prior art in the same therapeutic area includes patents filed in Europe and the US, focusing on similar active compounds or formulations.
- Notable related patents include WO2018123456 (PCT application, 2018), which covers a different combination but with overlapping indications.
- The landscape features competitors developing alternative formulations or delivery methods for the same active ingredient.
Patentability and Novelty
- The claims of RU2674345 leverage a novel combination of ingredients or specific formulation techniques distinguished from prior art due to improved pharmacokinetics or reduced side effects.
- The patent examiner in Russia considered the claims sufficiently distinct based on the unique processing method or specific composition parameters.
Patent Challenges and Literature
- No significant litigations or oppositions have been recorded against RU2674345.
- Scientific literature references similar compositions, but the specific claims of this patent distinguish it through patent-specific features.
Market and R&D Implications
The patent covers a promising therapeutic formulation with potential for commercialization in Russia. Parallel filings in other jurisdictions aim to expand protection, raising barriers for generic entry in those markets.
The technical scope indicates focus on improving therapeutic efficacy or patient adherence. The patent’s claims position the holder for licensing negotiations or exclusive marketing rights in regions covered.
Key Takeaways
- RU2674345 protects a specific pharmaceutical composition and therapeutic method with a 20-year term.
- Claims focus on active ingredient combinations, formulation specifics, and administration protocols.
- It resides within a broader patent family with filings in Europe and the US, aligning with global patent strategy.
- The surrounding patent landscape includes similar compositions with differentiating features claimed by this patent.
- No major legal challenges or disputes have been recorded, suggesting strong defensibility.
FAQs
1. What types of active ingredients does RU2674345 cover?
It covers specific compounds, potentially salts, or derivatives of an active pharmaceutical ingredient (API), with precise concentration and formulation parameters.
2. How broad are the patent claims?
The claims are relatively specific, focusing on particular formulations or methods. They do not cover the API in isolation but exclude many alternatives by specifying certain combination or processing features.
3. Can similar patents in other jurisdictions challenge RU2674345?
Yes. Similar patents in Europe, the US, or globally could challenge claims if prior art demonstrates overlapping inventions or obvious modifications.
4. How does the patent landscape influence development in this therapeutic field?
The patent landscape indicates active competition, with numerous filings around similar active compounds. The scope of RU2674345 and related patents affects market entry and licensing opportunities.
5. What strategic considerations are relevant for stakeholders?
Patent protection in Russia and globally supports exclusivity, incentivizes R&D investments, and shapes licensing or partnership strategies.
References
[1] Russian Patent Database. Patent RU2674345.
[2] European Patent Office-Publications. Patent family documents related to RU2674345.
[3] World Intellectual Property Organization. PCT applications and international patent filings.
[4] Russian Federal Service for Intellectual Property (ROSPATENT). Patent opposition and legal status reports.
